These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36106376)

  • 21. Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
    Hirshfield KM; Tolkunov D; Zhong H; Ali SM; Stein MN; Murphy S; Vig H; Vazquez A; Glod J; Moss RA; Belyi V; Chan CS; Chen S; Goodell L; Foran D; Yelensky R; Palma NA; Sun JX; Miller VA; Stephens PJ; Ross JS; Kaufman H; Poplin E; Mehnert J; Tan AR; Bertino JR; Aisner J; DiPaola RS; Rodriguez-Rodriguez L; Ganesan S
    Oncologist; 2016 Nov; 21(11):1315-1325. PubMed ID: 27566247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
    Madison R; Schrock AB; Castellanos E; Gregg JP; Snider J; Ali SM; Miller VA; Singal G; Alexander BM; Venstrom JM; Chung JH
    Lung Cancer; 2020 Oct; 148():69-78. PubMed ID: 32823229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
    Tomlins SA; Hovelson DH; Suga JM; Anderson DM; Koh HA; Dees EC; McNulty B; Burkard ME; Guarino M; Khatri J; Safa MM; Matrana MR; Yang ES; Menter AR; Parsons BM; Slim JN; Thompson MA; Hwang L; Edenfield WJ; Nair S; Onitilo A; Siegel R; Miller A; Wassenaar T; Irvin WJ; Schulz W; Padmanabhan A; Harish V; Gonzalez A; Mansoor AH; Kellum A; Harms P; Drewery S; Falkner J; Fischer A; Hipp J; Kwiatkowski K; Lazo de la Vega L; Mitchell K; Reeder T; Siddiqui J; Vakil H; Johnson DB; Rhodes DR
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive genomic profiling of Japanese patients with thoracic malignancies: A single-center retrospective study.
    Hirakawa T; Doi M; Hamai K; Katsura R; Miyake S; Fujita S; Ueno S; Masuda K; Tanimoto T; Nishisaka T; Hinoi T; Hirasawa A; Ishikawa N
    Respir Investig; 2023 Nov; 61(6):746-754. PubMed ID: 37714093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Genomic Profiling Detects Hereditary Cancers and Confers Survival Advantage in Patients With Gynaecological Cancers.
    Ueda T; Tsubamoto H; Takimoto Y; Isono-Taniguchi R; Narita S; Nakagawa K; Wakimoto YU; Nishimura Y; Muroi Y; Nagahashi M; Hirota S; Sawai H; Shibahara H
    Anticancer Res; 2023 May; 43(5):2091-2101. PubMed ID: 37097652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
    Bryce AH; Egan JB; Borad MJ; Stewart AK; Nowakowski GS; Chanan-Khan A; Patnaik MM; Ansell SM; Banck MS; Robinson SI; Mansfield AS; Klee EW; Oliver GR; McCormick JB; Huneke NE; Tagtow CM; Jenkins RB; Rumilla KM; Kerr SE; Kocher JA; Beck SA; Fernandez-Zapico ME; Farrugia G; Lazaridis KN; McWilliams RR
    Oncotarget; 2017 Apr; 8(16):27145-27154. PubMed ID: 28423702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences.
    Tóth E; Kürönya Z; Soós E; Pintér T; Butz H; Horváth Z; Csernák E; Grolmusz VK; Székely J; Straussz T; Lövey J; Jánvári L; Báthory-Fülöp L; Nagy P; Polgár C; Patócs A
    Acta Oncol; 2024 Jun; 63():433-440. PubMed ID: 38881341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronological improvement in precision oncology implementation in Japan.
    Sunami K; Naito Y; Komine K; Amano T; Ennishi D; Imai M; Kage H; Kanai M; Kenmotsu H; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Saigusa Y; Yoshino T
    Cancer Sci; 2022 Nov; 113(11):3995-4000. PubMed ID: 35976133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study.
    Takada K; Kubo T; Kikuchi J; Yoshida M; Murota A; Arihara Y; Nakamura H; Nagashima H; Tanabe H; Sugita S; Tanaka Y; Miura A; Ohhara Y; Ishiguro A; Yokouchi H; Kawamoto Y; Mizukami Y; Ohnishi H; Kinoshita I; Sakurai A
    Front Oncol; 2022; 12():988527. PubMed ID: 36119486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
    Leroy K; Audigier Valette C; Alexandre J; Boussemart L; Chiesa J; Deldycke C; Gomez-Rocca C; Hollebecque A; Lehmann-Che J; Lemoine A; Mansard S; Medioni J; Monnet I; Mourah S; Pierret T; Spaëth D; Civet A; Galoin S; Italiano A
    PLoS One; 2023; 18(9):e0291495. PubMed ID: 37708140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
    Kang H; Pettinga D; Schubert AD; Ladenson PW; Ball DW; Chung JH; Schrock AB; Madison R; Frampton GM; Stephens PJ; Ross JS; Miller VA; Ali SM
    Oncologist; 2019 Jun; 24(6):791-797. PubMed ID: 30373905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
    Shirota H; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Tada H; Shimada M; Niihori T; Aoki Y; Sugiyama I; Kawamura M; Yasuda J; Suzuki S; Iwaya T; Saito M; Saito T; Shibata H; Furukawa T; Ishioka C
    Cancer Med; 2023 Mar; 12(5):6170-6181. PubMed ID: 36251535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.
    Wheler JJ; Janku F; Naing A; Li Y; Stephen B; Zinner R; Subbiah V; Fu S; Karp D; Falchook GS; Tsimberidou AM; Piha-Paul S; Anderson R; Ke D; Miller V; Yelensky R; Lee JJ; Hong DS; Kurzrock R
    Cancer Res; 2016 Jul; 76(13):3690-701. PubMed ID: 27197177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
    Stockley TL; Oza AM; Berman HK; Leighl NB; Knox JJ; Shepherd FA; Chen EX; Krzyzanowska MK; Dhani N; Joshua AM; Tsao MS; Serra S; Clarke B; Roehrl MH; Zhang T; Sukhai MA; Califaretti N; Trinkaus M; Shaw P; van der Kwast T; Wang L; Virtanen C; Kim RH; Razak AR; Hansen AR; Yu C; Pugh TJ; Kamel-Reid S; Siu LL; Bedard PL
    Genome Med; 2016 Oct; 8(1):109. PubMed ID: 27782854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
    Tsimberidou AM; Hong DS; Wheler JJ; Falchook GS; Janku F; Naing A; Fu S; Piha-Paul S; Cartwright C; Broaddus RR; Nogueras Gonzalez GM; Hwu P; Kurzrock R
    J Hematol Oncol; 2019 Dec; 12(1):145. PubMed ID: 31888672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
    van Geelen CT; Savas P; Teo ZL; Luen SJ; Weng CF; Ko YA; Kuykhoven KS; Caramia F; Salgado R; Francis PA; Dawson SJ; Fox SB; Fellowes A; Loi S
    Breast Cancer Res; 2020 Aug; 22(1):91. PubMed ID: 32811538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
    Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
    Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies.
    Matsuo M; Hashimoto K; Kogo R; Jiromaru R; Hongo T; Manako T; Nakagawa T
    In Vivo; 2023; 37(5):2147-2154. PubMed ID: 37652518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An approach for improvement of the accuracy of cancer gene panel testing.
    Imoto K; Yamamoto H; Ohkawa C; Shimada N; Ikuzawa R; Takeda H; Ohhara T; Kojima Y; Furuya N; Motoyoshi A; Migita O; Kuga A; Keira T; Wakamatsu H; Sato T; Oike N; Koike J; Yamano Y; Sunakawa Y
    Int J Clin Oncol; 2024 May; 29(5):571-581. PubMed ID: 38472663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.